Hereditary breast and ovarian cancer: from genes to molecular targeted therapies-Reference-Cited by-同舟云学术

Hereditary breast and ovarian cancer: from genes to molecular targeted therapies

Published:2023-07-16 Issue:8 Volume:60 Page:640-650
ISSN:1040-8363
Container-title:Critical Reviews in Clinical Laboratory Sciences
language:en
Short-container-title:Critical Reviews in Clinical Laboratory Sciences

Author:

Ponti Giovanni¹^ORCID,De Angelis Carmine²,Ponti Rosamaria²,Pongetti Linda³,Losi Lorena⁴,Sticchi Alberto³,Tomasi Aldo¹,Ozben Tomris⁵^ORCID

Affiliation:

1. Division of Clinical Pathology, Department of Surgical, Medical, Dental and Morphological Sciences with Interest in Transplant, Oncological and Regenerative Medicine, University of Modena and Reggio Emilia, Modena, Italy

2. Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy

3. Dermatology Unit, Department of Surgical, Medical, Dental and Morphological Sciences Related to Transplant, Oncology and Regenerative Medicine, University of Modena and Reggio Emilia, Modena, Italy

4. Department of Life Sciences, Unit of Pathology, University of Modena and Reggio Emilia, Modena, Italy

5. Specialist in Clinical Biochemistry Akdeniz University, Department of Clinical Biochemistry, Antalya Turkey University of Modena and Reggio Emilia, Clinical and Experimental Medicine, Modena, Italy

Publisher

Informa UK Limited

Subject

Biochemistry (medical),Clinical Biochemistry,General Biochemistry, Genetics and Molecular Biology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10408363.2023.2234488

Reference53 articles.

1. Retrospective NGS Study in High-risk Hereditary Cancer Patients at Masaryk Memorial Cancer Institute

2. Defects in MMR Genes as a Seminal Example of Personalized Medicine: From Diagnosis to Therapy

3. Immunotherapy in colorectal cancer: rationale, challenges and potential

4. PD-1 Blockade in Tumors with Mismatch-Repair Deficiency

5. Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair–Deficient/Microsatellite Instability–High Metastatic Colorectal Cancer

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The neoantigens derived from transposable elements – A hidden treasure for cancer immunotherapy;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-09

2. BRCA Testing for Patients Treated in Italy: A National Survey of Breast Centers Associated with Senonetwork;Current Oncology;2024-06-30

3. Organoids in ovarian cancer: a platform for disease modeling, precision medicine, and drug assessment;Journal of Cancer Research and Clinical Oncology;2024-03-20

4. DNA/RNA-based electrochemical nanobiosensors for early detection of cancers;Critical Reviews in Clinical Laboratory Sciences;2024-03-07

5. Reclassifying BRCA1 c.4358-2A > G and BRCA2 c.475 + 5G > C variants from “Uncertain Significance” to “Pathogenic” based on minigene assays and clinical evidence;Journal of Cancer Research and Clinical Oncology;2024-02-01